Keyphrases
Treatment Outcome
57%
National Cohort Study
50%
Phosphoinositide 3-kinase (PI3K)
50%
Poor Prognostic Factors
50%
Regulatory T Cells
50%
Diffuse Large B-cell Lymphoma (DLBCL)
50%
Primary Peritoneal Cancer
50%
Plasmablastic Lymphoma
50%
Muscle Metastasis
50%
Human Cancer
50%
PIK3C3
50%
Aplastic Anemia
50%
Coronavirus Disease 2019 Vaccine
50%
Catalytic Subunit
50%
Population Database
50%
Hematopathologist
50%
Treg
30%
Autophagy
28%
Transplant Surgeon
25%
ChAdOx1 nCoV-19 Vaccine
25%
Radiologic Presentation
25%
Neutrophil Count
20%
Healthy Volunteers
20%
Immature Dendritic Cells
20%
In-breast Recurrence
16%
Chest Wall Invasion
16%
National Comprehensive Cancer Network Guidelines
16%
Pathogen Survey
16%
EBV DNA
16%
Type Revision
16%
Benign Lesion
16%
Peritoneal Seeding
14%
Tumor Cell Proliferation
14%
Asia
12%
Taiwan
12%
Immunosuppressive Therapy
12%
Severe Aplastic Anemia
12%
National Health Insurance Research Database (NHIRD)
12%
Hematopoietic Stem Cell Transplantation
12%
Bone Marrow Failure
12%
Androgens
12%
InvA
10%
Differentia
10%
T Cell Subsets
10%
Prognostic Score
10%
Host Immune Response
10%
Adaptive Immunity
10%
CD8+
10%
Dendritic Cells
10%
Univariate Analysis
10%
Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
50%
Plasmablastic Lymphoma
50%
Pathologist
50%
Immune Cell Infiltration
50%
Muscle Metastasis
50%
Patient Referral
50%
Central Nervous System
50%
Aplastic Anemia
50%
Posttransplant Lymphoproliferative Disease
50%
Hemophagocytic Lymphohistiocytosis Syndrome
33%
Atropine Methyl Bromide
30%
T Cell
28%
Dendritic Cell
21%
Immune Response
21%
NK T Cell Lymphoma
16%
Hematopathology
16%
Disease Management
16%
B Cell
16%
Malignant Neoplasm
16%
Neoplasm
16%
RNA Immunization
16%
Transplant Surgeon
16%
Cellular Infiltration
14%
Cytotoxic T-Cell
14%
Biopsy Technique
14%
Orthology
12%
Phosphatidylinositol 3 Phosphate
12%
Metabolic Stress
12%
Androgen
10%
Bone Marrow Failure
10%
Hematopoietic Stem Cell Transplantation
10%
Immunosuppressive Treatment
10%
Diseases
7%
Immunotherapy
7%
Overall Survival
7%
Granzyme B
7%
Lymphoma Cell
7%
Treatment Response
7%
Immunocompetent Cell
7%
Memory T Cell
7%
Prognostic Factor
7%
Membrane Protein
7%
Thymocyte Antibody
5%
Multivariate Analysis
5%
Rare Disease
5%
Identified Patient
5%
Catastrophic Illness
5%
Pancytopenia
5%
Age Distribution
5%
Immunology and Microbiology
B Cell
100%
T Cell
78%
T Cell Receptor
50%
Regulatory T Cell
50%
Immune Cell Infiltration
50%
Wild Type
50%
Central Nervous System
50%
Promoter Region
50%
Natural Killer T Cell
50%
Dendritic Cell
42%
Immunocompetent Cell
21%
Cell Invasion
16%
Cell Proliferation
16%
Plasmid
16%
Cell Infiltration
14%
Lymphocyte
14%
Cytotoxic T Cell
14%
HLA-DR
14%
Immune Response
14%
Clonal Variation
12%
Cancer Specific Survival
8%
Cell Function
8%
Muscle
8%
Cancer Cell
8%
Xenograft
8%
Receptor Gene
8%
Plasmacytoid Dendritic Cell
8%
Gene Expression
8%
Protein Expression
8%
Memory T Cell
7%
CD4 CD8 Ratio
7%
Survival Factor
7%
Granzyme B
7%
CD25
7%
Immunotherapy
7%
T Cell Subset
7%
Adaptive Immune System
7%
T Helper Cell
7%
CD4
7%
CD83
7%
CD3 Antigen
7%
Monocyte Count
7%
Neutrophil Count
7%
Leukocyte Count
7%
Host Immune Response
7%
Lymphoma Cell
7%
Overall Survival
7%
